MilliDrop
- Founded in: 2015
- Number of employees: 9
- Country: France
- Investors: Quadrivium I (Seventure Partners)
- Website: millidrop.com
Which input provides your business model/core technology towards a bio-based economy?
MilliDrop develops enabling technologies for the bio-based economy. Its droplet-based millifluidics technology brings high-throughput at lower cost per assay. This will lead to a better knowledge of microorganisms and faster time to products.
Which market/clients do you address and which short-term/long-term goals do you have?
MilliDrop provides its disruptive solutions to academic laboratories and corporates developing bio-based products for agriculture, food & feed, chemistry and healthcare. MilliDrop aims to launch its second instrument by early-2021 to reach an installed base of 400 machines by 2024.
What makes your approach unique compared to other stakeholders in the field?
MilliDrop technology enables to miniaturize samples and fluidically automate processes. As a consequence, the full microbiology workflow (isolation, culture, measurement) can be integrated in a benchtop instrument. Thousands of experiments can be carried out simultaneously, for a fraction of the price it would cost with standard methods.
You can meet Millidrop Ltd at EFIB in Brussels on 30 September – 2 October 2019.